Jim Cramer, host of CNBC's Mad Money, recently discussed ways investors should handle navigating the current difficult market environment.
And he suggested three stocks to consider buying.
DON'T MISS: Why Jim Cramer Isn't Fazed by the Fed Rate Hike
The U.S. companies Cramer enthusiastically discussed are Johnson & Johnson (JNJ), Eli Lilly (LLY) and Procter & Gamble (PG).
"What do all three of these have in common? How about the fact that they're amazing American companies, with stocks that get cheaper as they go down," Cramer said, according to CNBC.
For example, several lawsuits involving Johnson & Johnson's talc powder had been damaging the company's stock price for years.
"But J&J’s recently announced settlement with many of the claimants leaves the stock 'free to run,' offering upside in a company that has historically been a 'great' buy," Cramer said, according to CNBC.
Cramer said the following about Eli Lilly and Proctor & Gamble, CNBC reported.
At Lilly, the stock price took a hit when investor excitement over a highly anticipated diabetes drug was dampened by investor fears that Federal Reserve maneuvering could weaken defensive stocks. But the company isn’t a “one-trick pony,” Cramer said, so investors should look to buy the dip and trust in Lilly’s research and development.
And finally, at P&G, Cramer thinks that there’s a “grudging recognition” that the stock of the consumer goods company is underpriced. It suffered from a flight as investors moved from safer picks into technology companies, but is poised for a renaissance and has come off its lows, Cramer said.
Get exclusive access to portfolio managers and their proven investing strategies with Real Money Pro. Get started now.
